You are here: Industry Insights > e

News List

Predicted Top 5 Worldwide Selling Drugs in 2025: A Market Update David Orchard-Webb
June 23, 2025
Keytruda ($30B sales), Ozempic, Mounjaro, Dupixent, and Skyrizi dominate 2025's pharma market, targeting oncology, diabetes/obesity, and immunology with breakthrough biologics and multi-indication strategies.
Diabetes and Metabolic Disorders: The Approval of Teplizumab David Orchard-Webb
June 23, 2025
Teplizumab, the first disease-modifying therapy for Type 1 diabetes, delays disease onset by ~4 years in high-risk individuals. Priced at $194,000 per course, it redefines early intervention despite cost barriers.
Apeloa Pharmaceutical releases first ESG PharmaSources
May 12, 2025
Apeloa Pharmaceutical has released its first sustainability report. Apeloa’s 2024 Environmental, Social and Governance (ESG) report marks the start of continuous and responsible disclosure into the future.
How to select automation components for your pharma equipment Muhammad Asim Niazi
June 13, 2025
Automation components?? (sensors, motors, PLCs) are selected for ??pharmaceutical equipment?? based on ??application requirements??, ??output signals??, ??physical dimensions??, ??power ratings??, and ??safety compliance??.
Time and Temperature Sensitive Pharmaceutical Products Muhammad Asim Niazi
June 13, 2025
Temperature-sensitive pharmaceuticals?? require strict ??cold chain control?? (2°C–8°C or frozen) during storage/transport to prevent ??degradation risks??. Mandatory ??monitoring?? and ??alarm systems?? ensure regulatory compliance.
ESG related equipment in the pharmaceutical industry Muhammad Asim Niazi
June 13, 2025
ESG principles?? integrate ??energy-efficient equipment?? , ??OHS systems?? (biosafety cabinets), and ??digital compliance tools?? (EBR, BMS) to achieve sustainability and regulatory governance in pharma manufacturing.
Beyond Antibiotics: The Expanding Role of Anti-Infective APIs in Bacterial Infection Suzanne Elvidge
June 13, 2025
Beyond antibiotics??, novel anti-infective approaches include ??AMPs?? targeting biofilms, ??FMT capsules?? ,nanoparticle delivery systems??, and ??synbiotics?? to combat the global ??AMR crisis??.
2025 Q1: Oncology Business Competition Among MNCs Xiaobin
June 04, 2025
How did MNCs fare in the oncology field during Q1 of this year?
Oral Solid Dosage Forms: How to Ensure Compliance and Efficacy Saher Haider
June 04, 2025
Oral solid dosage forms (OSDs) comprise 66% to 70% of all prescribed and dispensed products worldwide.
Alzheimer’s Disease: Charting the Course from Plaques to Promise Muhammad Farhan Khalid
May 28, 2025
New Tools，New Hope，New Frontier